Experimental evidence suggests that PXR activation by vitamin K2 can potentially alleviate the symptoms of IBD by mitigating inflammation, maintaining intestinal homeostasis, and promoting the detoxification of harmful compounds [84,85,86]. The gene discussed is NR1I2; the disease is irritable bowel syndrome.